Abstract
Sixteen chelating agents were examined to determine their relative efficacy as antidotes in acute zinc acetate intoxication in mice after i.p. administration. For a i. p. dose of 0.49 mmol/kg (LD50) of zinc acetate, the i. p. administration of chelating agents at a 2∶1 and 5∶1 mole ratio resulted in a significant antidotal action for EDTA, DTPA, CDTA, d-penicillamine (d-PA), DMPS and DMSA. EGTA, l-cysteine, triethylentetraamine (TTHA), N-acetylcysteine (NAC), 4,5-dihydroxi-1,3-benzenedisulfonic acid (Tiron), sodium salicylate, glutathione, sodium diethyldithiocarbamate (DDC), 6-mercaptopurine and N-acetyl-d, l-penicillamine (NAPA) were not effective for acute zinc acetate poisoning. The therapeutic indices and therapeutic effectiveness of the most effective chelators were, respectively: EDTA (5.0, 7.0), DTPA (7.3, 13.7), CDTA (8.6, 6.3), d-PA (4.6, 1.9), DMPS (1.3, 1.0), DMSA (3.2, 5.4). DTPA, CDTA, and EDTA appear to be the most effective agents of those tested in offsetting acute zinc intoxication in mice.
This is a preview of subscription content, log in via an institution to check access.
References
Aposhian HV, Tadlock CH, Moon T (1981) Protection of mice against the lethal efects of sodium arsenite. A quantitative comparison of a number of chelating agents. Toxicol Appl Pharmacol 61: 385–392
Basinger MA, Jones MM (1981) Chelate antidotal efficacy in acute zinc intoxication. Res Commun Chem Pathol Pharmacol 33: 263–272
Basinger MA, Gibbs SJ, Forti RL, Mitchell WM, Jones MM (1985) Antidotes for gold intoxication in mice. J Rheumatol 12: 274–278
Brocks JA, Reid H, Glazer G (1977) Acute intravenous zinc poisoning. Br Med J 28: 1390–1391
Brown MA, Thorn JV, Orth GL, Cova P, Juarez J (1964) Food poisoning involving zinc contamination. Arch Environ Health 8: 657–660
Domingo JL, Llobet JM, Corbella J (1985) Protection of mice against the lethal effects of sodium metavanadate: A quantitative comparison of a number of chelating agents. Toxicol Lett 26: 95–99
Elsas LJ, Hayslett JP, Spargo BH, Durant JL, Rosenberg LE (1971) Wilson's disease with reversible renal tubular dysfunction. Correlation with proximal tubular ultrastructure. Ann Int Med 75: 427–433
Eybl V, Sykora J, Mertl F (1970) Einfluß der Ca-Komplexe der Aminopolycarbonsäuren auf die Ausscheidung und die Verteilung des Zinks. Z Ges Exp Med 152: 274–283
Halsted JA, Ronaghy HA, Abadi P, Haghshenass M, Amirhakimi GH, Barakat RM, Reinhold JG (1972) Zinc deficiency in man: The Shiraz experiment. Am J Med 53: 277–284
Jones MM (1984) Antagonists for toxic heavy metals. Proc West Pharmacol Soc 27: 163–167
Jones MM, Basinger MA (1982) A hypothesis for the selection of chelate antidotes for toxic metals. Med Hypotheses 9: 445–453
Lichtfield JT, Wilcoxon F (1949) A simplified method of evaluating dose-effect experiments. J Pharmacol Exp Ther 96: 99–113
Llobet JM, Domingo JL, Gómez M, Tomas J, Corbella J (1987) Acute toxicity studies of aluminium compounds: Antidotal efficacy of several chelating agents. Pharmacol Toxicol 60: 280–283
Murphy JV (1970) Intoxication following ingestion of elemental zinc. JAMA 212: 2119–2120
Prasad AS (1979) Clinical, biochemical, and pharmacological role of zinc. Annu Rev Pharmacol Toxicol 20: 393–426
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Llobet, J.M., Domingo, J.L. & Corbella, J. Antidotes for zinc intoxication in mice. Arch Toxicol 61, 321–323 (1988). https://doi.org/10.1007/BF00364857
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00364857